Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA608197
Max Phase: Preclinical
Molecular Formula: C37H68O10
Molecular Weight: 672.94
Molecule Type: Small molecule
Associated Items:
ID: ALA608197
Max Phase: Preclinical
Molecular Formula: C37H68O10
Molecular Weight: 672.94
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCC[C@@H](O)[C@@H]1CC[C@@H]([C@@H](O)CC[C@H](O)[C@@H]2CC[C@@H](CCCCCCC[C@@H](O)C[C@]3(O)C(=O)O[C@H](C)[C@H]3O)O2)O1
Standard InChI: InChI=1S/C37H68O10/c1-3-4-5-6-7-8-12-15-18-29(39)33-23-24-34(47-33)31(41)21-20-30(40)32-22-19-28(46-32)17-14-11-9-10-13-16-27(38)25-37(44)35(42)26(2)45-36(37)43/h26-35,38-42,44H,3-25H2,1-2H3/t26-,27-,28-,29-,30+,31+,32+,33+,34+,35-,37-/m1/s1
Standard InChI Key: OHJZOTNXFNMAJF-HBKGSMMCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 672.94 | Molecular Weight (Monoisotopic): 672.4812 | AlogP: 4.99 | #Rotatable Bonds: 25 |
Polar Surface Area: 166.14 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.29 | CX Basic pKa: | CX LogP: 5.32 | CX LogD: 5.32 |
Aromatic Rings: 0 | Heavy Atoms: 47 | QED Weighted: 0.06 | Np Likeness Score: 1.60 |
1. Tormo JR, Estornell E, Gallardo T, González MC, Cavé A, Granell S, Cortes D, Zafra-Polo MC.. (2001) Gamma-lactone-Functionalized antitumoral acetogenins are the most potent inhibitors of mitochondrial complex I., 11 (5): [PMID:11266168] [10.1016/s0960-894x(01)00036-1] |
Source(1):